"Global Hormonal Contraceptive Market Overview:
Global Hormonal Contraceptive Market is expected to grow at a significant rate during the forecast period 2025-2032, with 2024 as the base year.
Global Hormonal Contraceptive Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Hormonal Contraceptive involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Hormonal Contraceptive Market:
The Hormonal Contraceptive Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Hormonal Contraceptive Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Hormonal Contraceptive Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Hormonal Contraceptive market has been segmented into:
Oral Contraceptives
Skin Patches
Intrauterine Devices
By Application, Hormonal Contraceptive market has been segmented into:
Progestin Only
Combined Hormone Contraceptives
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Hormonal Contraceptive market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Hormonal Contraceptive market.
Top Key Players Covered in Hormonal Contraceptive market are:
Allergan plc
Afaxys
Inc.
Merck & Co.
Inc.
Pfizer Inc.
Mylan N.V.
Bayer AG
Agile Therapeutics
Novartis AG
"
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Hormonal Contraceptive Market by Type
4.1 Hormonal Contraceptive Market Snapshot and Growth Engine
4.2 Hormonal Contraceptive Market Overview
4.3 Oral Contraceptives
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Oral Contraceptives: Geographic Segmentation Analysis
4.4 Skin Patches
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Skin Patches: Geographic Segmentation Analysis
4.5 Intrauterine Devices
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Intrauterine Devices: Geographic Segmentation Analysis
Chapter 5: Hormonal Contraceptive Market by Application
5.1 Hormonal Contraceptive Market Snapshot and Growth Engine
5.2 Hormonal Contraceptive Market Overview
5.3 Progestin Only
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Progestin Only: Geographic Segmentation Analysis
5.4 Combined Hormone Contraceptives
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Combined Hormone Contraceptives: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Hormonal Contraceptive Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 ALLERGAN PLC
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 AFAXYS
6.4 INC.
6.5 MERCK & CO.
6.6 INC.
6.7 PFIZER INC.
6.8 MYLAN N.V.
6.9 BAYER AG
6.10 AGILE THERAPEUTICS
6.11 NOVARTIS AG
Chapter 7: Global Hormonal Contraceptive Market By Region
7.1 Overview
7.2. North America Hormonal Contraceptive Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Oral Contraceptives
7.2.4.2 Skin Patches
7.2.4.3 Intrauterine Devices
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Progestin Only
7.2.5.2 Combined Hormone Contraceptives
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Hormonal Contraceptive Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Oral Contraceptives
7.3.4.2 Skin Patches
7.3.4.3 Intrauterine Devices
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Progestin Only
7.3.5.2 Combined Hormone Contraceptives
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Hormonal Contraceptive Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Oral Contraceptives
7.4.4.2 Skin Patches
7.4.4.3 Intrauterine Devices
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Progestin Only
7.4.5.2 Combined Hormone Contraceptives
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Hormonal Contraceptive Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Oral Contraceptives
7.5.4.2 Skin Patches
7.5.4.3 Intrauterine Devices
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Progestin Only
7.5.5.2 Combined Hormone Contraceptives
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Hormonal Contraceptive Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Oral Contraceptives
7.6.4.2 Skin Patches
7.6.4.3 Intrauterine Devices
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Progestin Only
7.6.5.2 Combined Hormone Contraceptives
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Hormonal Contraceptive Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Oral Contraceptives
7.7.4.2 Skin Patches
7.7.4.3 Intrauterine Devices
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Progestin Only
7.7.5.2 Combined Hormone Contraceptives
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Hormonal Contraceptive Scope:
|
Report Data
|
Hormonal Contraceptive Market
|
|
Hormonal Contraceptive Market Size in 2025
|
USD XX million
|
|
Hormonal Contraceptive CAGR 2025 - 2032
|
XX%
|
|
Hormonal Contraceptive Base Year
|
2024
|
|
Hormonal Contraceptive Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Allergan plc, Afaxys, Inc., Merck & Co., Inc., Pfizer Inc., Mylan N.V., Bayer AG, Agile Therapeutics, Novartis AG.
|
|
Key Segments
|
By Type
Oral Contraceptives
Skin Patches
Intrauterine Devices
By Applications
Progestin Only
Combined Hormone Contraceptives
|
